Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Bacillus Media Shape γ-Glutamyl Peptide Production
2026-09-28
This Food Bioscience study separates the effects of Bacillus strain identity and growth-medium composition on γ-glutamyl dipeptide and tripeptide production. Its comparative design shows that hemoglobin hydrolysate often supports higher peptide accumulation than brain heart infusion broth, while glutathione formation remains strain- and medium-dependent.
-
FLAG tag Peptide: Assay Design for Exosome Biology
2026-09-28
The FLAG tag Peptide (DYKDDDDK) is more than an elution reagent: used thoughtfully, it can help separate protein recovery from biological interpretation. This article connects FLAG-tag workflow decisions to the RAB31-dependent exosome pathway and explains what affinity capture can—and cannot—show.
-
RAB31 Defines an ESCRT-Independent Exosome Pathway
2026-09-27
The study identifies RAB31 as a regulator of an ESCRT-independent route that sorts EGFR into intraluminal vesicles and helps preserve multivesicular endosomes from lysosomal degradation. Its findings connect flotillin-dependent vesicle formation with control of RAB7, offering a mechanistic framework for how some endosomal cargo can enter secreted exosomes.
-
HA Tag Peptide for Mechanistic Protein Studies
2026-09-26
Learn how the Influenza Hemagglutinin (HA) Peptide can support tagged-protein enrichment while keeping capture separate from modification-state measurement. A mechanistic case study on mutant IDH1 shows where competitive elution fits—and where it does not—in rigorous assay design.
-
USP18 Limits Pyroptosis Through GSDMD Autophagy
2026-09-25
Wang et al. report that USP18 limits pyroptosis by recruiting the E3 ligase MIB2 to ubiquitinate GSDMD at K168, marking it for selective autophagic degradation. The findings identify a mechanism for controlling GSDMD abundance and suggest that protein turnover, alongside proteolytic activation, can shape inflammatory cell death.
-
How Tango1, Sec16 and Sec12 Define ER Exit Sites
2026-09-25
A Drosophila study supports a cooperative model in which Sec12, Sec16 and the animal-specific protein Tango1 make distinct contributions to ER exit site organization. Its findings position Sec12 upstream of Sec16 and Tango1 concentration, while implicating Tango1 in ER–Golgi coupling and both Tango1 and Sec16 in the recruitment or concentration of coat components.
-
Hexa His Tag Peptide in Binding Assays
2026-09-24
Hexa His tag peptide supports cleaner recovery of His-tagged proteins during antibody-based immunoprecipitation. This article connects its competitive-elution role to AptaBLE’s emerging computational approach to protein-binding analysis—and clarifies where the two methods do and do not intersect.
-
Gly-Gly-Phe-Gly: Practical Linker Workflows
2026-09-24
Gly-Gly-Phe-Gly (GGFG) offers a compact, sequence-defined spacer for peptide engineering and bioconjugation studies. This guide turns its linker role into a practical workflow, with small-scale screening, analytical checks, and clear limits on what the peptide alone can establish.
-
Influenza Hemagglutinin (HA) Peptide for Co-IP
2026-09-23
Use the HA tag peptide both to detect tagged proteins and to competitively release them from anti-HA immunoprecipitation matrices. This workflow-focused guide shows how to apply it to protein-interaction studies relevant to PRKX–PD-L1 biology, while distinguishing practical assay recommendations from findings reported in the reference study.
-
Influenza Hemagglutinin (HA) Peptide Workflow
2026-09-23
Use the Influenza Hemagglutinin (HA) Peptide as a clean competitive elution reagent for HA-tagged protein complexes, purification, and interaction studies. This workflow combines practical handling guidance with assay design insights inspired by a recent gastric cancer study of PRKX-dependent PD-L1 stabilization.
-
c-Myc Peptide: Assay Control by Design
2026-09-22
The c-Myc Peptide is more than a blocking reagent: it is a defined competitive control for interpreting antibody-based assays. This guide connects c-Myc tag peptide displacement with rigorous assay architecture and the mechanistic lessons of selective IRF3 autophagy research.
-
Fast-Dissociating Antibodies from Single-Molecule Screening
2026-09-22
Miyoshi et al. developed a semi-automated single-molecule TIRF assay that identifies specific monoclonal antibodies with rapid antigen dissociation directly from hybridoma cultures. The resulting Fab probes supported multiplexable super-resolution imaging and revealed rapid espin turnover within apparently stable F-actin cores of inner-ear stereocilia.
-
Laminin (925-933) Protocol and QC Guide
2026-09-21
Laminin (925-933) is a defined Laminin B1 chain peptide for controlled cell attachment, migration, and chemotaxis workflows. This guide covers preparation, assay setup, quality controls, and interpretation boundaries; it is for research use only and should not be treated as a diagnostic, therapeutic, or universally validated metastasis model reagent.
-
HBTU Workflows for Precision Peptide Synthesis
2026-09-21
HBTU supports rapid, mild peptide bond formation for solid-phase construction of complex enzyme-responsive sequences. This workflow connects carboxylic acid activation with practical assay design for zwitterionic peptide assemblies, while clearly separating synthesis performance from biological and translational claims.
-
NEDD4L–PRMT5 in Colorectal Liver Metastasis
2026-09-20
This 2025 study identifies the HECT E3 ligase NEDD4L as a suppressor of colorectal cancer liver metastasis and defines PRMT5 as its degradation substrate. The findings connect NEDD4L-dependent PRMT5 turnover with reduced AKT1 arginine methylation and inhibition of AKT/mTOR signaling, providing a mechanistic framework for studying metastatic colonization.